Bioactive Compounds
-
B3249 VanoxerineSummary: potent and selective DRI (Dopamine reuptake inhibitor) -
B3255 MeisoindigoSummary: Apoptosis inducer;potential agent for AML -
B1163 MK-4827 hydrochlorideSummary: PARP1/PARP2 inhibitor -
C5850 SD 1692 CitationSummary: selective ATP competitive inhibitor of the MAP kinases p38α and p38β -
A1054 Angiotensin 1/2 (1-7) amideSummary: Vasoconstrictor -
B8480 BroxaldineSummary: An antiprotozoal drug -
B5162 T 0156 hydrochlorideSummary: inhibitor of phosphodiesterase type 5 (PDE5) -
B5802 ICA 121431Summary: human NaV1.3 and NaV1.1 channels inhibitor -
B8001 GNE-477Summary: dual PI3K/mTOR inhibitor -
B5873 Spautin-11 CitationTarget: Deubiquitinating enzymes (DUBs)|AutophagySummary: Novel autophagy inhibitor
